H
Power Law company profile
Horizon Therapeutics
Biotech & Life Sciences · Dublin, Ireland · Founded 2005 · IPO 2011 Decacorn
Valuation
$28B
Market cap · 2026
Revenue
$3.63B
Latest reported FY
Global footprint
Where Horizon Therapeutics has talent and traffic
Web traffic by country
850
monthly visits
across markets
across markets
🇺🇸 United States105.9%
Patent intelligence
$100M patent portfolio · 70 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$100M
0.35% of market cap · 1.6× smaller than top peer Amicus Therapeutics ($164M)
70 active patent families
Where Horizon Therapeutics innovates
PharmacologyPharmaceutical drugProdrugTherapeutic monitoringPEGylation
Above peer median on Legal, Strategic, Technology
Quality vs same-sector peers
Horizon Therapeutics on the five Patsnap quality dimensions
Horizon Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Horizon Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Horizon Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Horizon Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.